Maxcyte.
158 announcements.
158 announcements.
| Time | Date | Ticker | Company | Announcement |
|---|---|---|---|---|
| 07:00 | 26-06-2025 | MXCT | Maxcyte | Cancellation - Maxcyte Inc |
| 07:00 | 25-06-2025 | MXCT | Maxcyte | Last Day of Dealings on AIM |
| 07:00 | 19-06-2025 | MXCT | Maxcyte | Result of Annual General Meeting |
| 07:00 | 12-06-2025 | MXCT | Maxcyte | Holding(s) in Company |
| 07:00 | 11-06-2025 | MXCT | Maxcyte | MaxCyte and Ori Biotech Announce Collaboration |
| 09:33 | 06-06-2025 | MXCT | Maxcyte | Holding(s) in Company |
| 14:16 | 05-06-2025 | MXCT | Maxcyte | Holding(s) in Company |
| 17:14 | 02-06-2025 | MXCT | Maxcyte | Total Voting Rights |
| 16:17 | 02-06-2025 | MXCT | Maxcyte | Holding(s) in Company |
| 07:06 | 29-05-2025 | MXCT | Maxcyte | Holding(s) in Company |
| 16:52 | 23-05-2025 | MXCT | Maxcyte | Holding(s) in Company |
| 16:26 | 23-05-2025 | MXCT | Maxcyte | Holding(s) in Company |
| 07:00 | 23-05-2025 | MXCT | Maxcyte | Holding(s) in Company |
| 15:12 | 16-05-2025 | MXCT | Maxcyte | Holding(s) in Company |
| 07:00 | 08-05-2025 | MXCT | Maxcyte | First Quarter 2025 Financial Results |
| 16:40 | 02-05-2025 | MXCT | Maxcyte | Total Voting Rights |
| 07:00 | 28-04-2025 | MXCT | Maxcyte | Filing of definitive proxy statement |
| 14:43 | 22-04-2025 | MXCT | Maxcyte | Holding(s) in Company |
| 14:37 | 22-04-2025 | MXCT | Maxcyte | Holding(s) in Company |
| 17:00 | 15-04-2025 | MXCT | Maxcyte | Holding(s) in Company |
| 07:00 | 15-04-2025 | MXCT | Maxcyte | Proposed cancellation of trading on AIM |
| 09:17 | 14-04-2025 | MXCT | Maxcyte | Holding(s) in Company |
| 07:00 | 10-04-2025 | MXCT | Maxcyte | MaxCyte to Report Q1 2025 Results on May 7, 2025 |
| 15:35 | 08-04-2025 | MXCT | Maxcyte | Holding(s) in Company |
| 10:14 | 26-03-2025 | MXCT | Maxcyte | Correction: Vesting of RSUs and PDMR Dealing |
| 07:00 | 26-03-2025 | MXCT | Maxcyte | Vesting of RSUs and PDMR Dealing |
| 10:30 | 25-03-2025 | MXCT | Maxcyte | Holding(s) in Company |
| 10:28 | 25-03-2025 | MXCT | Maxcyte | Holding(s) in Company |
| 10:22 | 25-03-2025 | MXCT | Maxcyte | Holding(s) in Company |
| 10:26 | 25-03-2025 | MXCT | Maxcyte | Holding(s) in Company |
| 09:06 | 24-03-2025 | MXCT | Maxcyte | Grant of Options, RSUs and PSUs and PDMR Dealing |
| 14:07 | 19-03-2025 | MXCT | Maxcyte | Holding(s) in Company |
| 07:00 | 12-03-2025 | MXCT | Maxcyte | Q4 & FY 2024 Financial Results |
| 15:38 | 04-03-2025 | MXCT | Maxcyte | Total Voting Rights |
| 15:23 | 19-02-2025 | MXCT | Maxcyte | Holding(s) in Company |
| 17:05 | 14-02-2025 | MXCT | Maxcyte | Holding(s) in Company |
| 16:12 | 13-02-2025 | MXCT | Maxcyte | Holding(s) in Company |
| 14:52 | 13-02-2025 | MXCT | Maxcyte | Holding(s) in Company |
| 07:00 | 07-02-2025 | MXCT | Maxcyte | Notice of Results |
| 07:00 | 04-02-2025 | MXCT | Maxcyte | Total Voting Rights |
| 15:18 | 31-01-2025 | MXCT | Maxcyte | Exercise of options and PDMR dealing |
| 07:00 | 30-01-2025 | MXCT | Maxcyte | MaxCyte® Acquires SeQure Dx |
| 15:05 | 29-01-2025 | MXCT | Maxcyte | Holding(s) in Company |
| 14:25 | 22-01-2025 | MXCT | Maxcyte | Holding(s) in Company |
| 09:13 | 21-01-2025 | MXCT | Maxcyte | Holding(s) in Company |
| 13:15 | 17-01-2025 | MXCT | Maxcyte | Holding(s) in Company |
| 16:00 | 15-01-2025 | MXCT | Maxcyte | Holding(s) in Company |
| 08:05 | 13-01-2025 | MXCT | Maxcyte | Preliminary Fourth Quarter and Full Year Results |
| 07:00 | 31-12-2024 | MXCT | Maxcyte | Exercise of options and PDMR dealing |
| 07:00 | 23-12-2024 | MXCT | Maxcyte | MaxCyte Announces Retirement of Board Member |
| 16:26 | 19-12-2024 | MXCT | Maxcyte | Holding(s) in Company |
| 15:31 | 18-12-2024 | MXCT | Maxcyte | Holding(s) in Company |
| 17:16 | 10-12-2024 | MXCT | Maxcyte | Holding(s) in Company |
| 17:12 | 10-12-2024 | MXCT | Maxcyte | Holding(s) in Company |
| 07:00 | 09-12-2024 | MXCT | Maxcyte | MaxCyte Streamlines Operations and Raises Guidance |
| 17:09 | 02-12-2024 | MXCT | Maxcyte | Total Voting Rights and Block Listing Return |
| 15:05 | 28-11-2024 | MXCT | Maxcyte | Holding(s) in Company |
| 15:05 | 28-11-2024 | MXCT | Maxcyte | Holding(s) in Company |
| 09:49 | 19-11-2024 | MXCT | Maxcyte | Holding(s) in Company |
| 07:00 | 07-11-2024 | MXCT | Maxcyte | Third Quarter 2024 Financial Results |
| 13:43 | 06-11-2024 | MXCT | Maxcyte | Exercise of options and PDMR dealing |
| 13:23 | 04-11-2024 | MXCT | Maxcyte | Total Voting Rights |
| 07:00 | 31-10-2024 | MXCT | Maxcyte | Exercise of options and PDMR dealing |
| 09:24 | 18-10-2024 | MXCT | Maxcyte | Grant of Options and Restricted Stock Units |
| 13:05 | 15-10-2024 | MXCT | Maxcyte | MaxCyte Appoints Cynthia Collins to Board |
| 13:00 | 11-10-2024 | MXCT | Maxcyte | Notice of Results |
| 13:05 | 10-10-2024 | MXCT | Maxcyte | MaxCyte Appoints Ali Soleymannezhad as CCO |
| 09:41 | 03-10-2024 | MXCT | Maxcyte | Exercise of options and PDMR dealing |
| 09:47 | 01-10-2024 | MXCT | Maxcyte | Exercise of options and PDMR dealing |
| 07:00 | 01-10-2024 | MXCT | Maxcyte | Total Voting Rights |
| 16:15 | 27-09-2024 | MXCT | Maxcyte | Holding(s) in Company |
| 15:29 | 27-09-2024 | MXCT | Maxcyte | Holding(s) in Company |
| 17:02 | 20-09-2024 | MXCT | Maxcyte | Holding(s) in Company |
| 07:00 | 16-09-2024 | MXCT | Maxcyte | TR-1: Notification of major holdings |
| 17:07 | 06-09-2024 | MXCT | Maxcyte | Exercise of options and PDMR dealing |
| 15:38 | 03-09-2024 | MXCT | Maxcyte | Total Voting Rights |
| 10:06 | 29-08-2024 | MXCT | Maxcyte | Exercise of options and PDMR dealing |
| 07:00 | 07-08-2024 | MXCT | Maxcyte | Second Quarter and Half-Year Results |
| 16:31 | 01-08-2024 | MXCT | Maxcyte | Total Voting Rights |
| 07:00 | 31-07-2024 | MXCT | Maxcyte | Exercise of options and PDMR dealing |
| 09:15 | 10-07-2024 | MXCT | Maxcyte | Notice of Results |
| 09:14 | 09-07-2024 | MXCT | Maxcyte | Change of Name of Nominated Adviser and Broker |
| 07:00 | 03-07-2024 | MXCT | Maxcyte | TR-1: Notification of major holdings |
| 11:18 | 02-07-2024 | MXCT | Maxcyte | Exercise of options and PDMR dealing |
| 07:00 | 02-07-2024 | MXCT | Maxcyte | Total Voting Rights |
| 14:34 | 27-06-2024 | MXCT | Maxcyte | Publication of Annual Report |
| 07:00 | 14-06-2024 | MXCT | Maxcyte | Grant of Options and Restricted Stock Units |
| 07:00 | 12-06-2024 | MXCT | Maxcyte | Result of AGM |
| 07:00 | 11-06-2024 | MXCT | Maxcyte | PDMR Dealing |
| 15:22 | 03-06-2024 | MXCT | Maxcyte | Total Voting Rights |
| 13:05 | 29-05-2024 | MXCT | Maxcyte | Participation in Upcoming Investor Conference |
| 14:55 | 14-05-2024 | MXCT | Maxcyte | Holding(s) in Company |
| 07:00 | 08-05-2024 | MXCT | Maxcyte | First Quarter Results |
| 07:00 | 03-05-2024 | MXCT | Maxcyte | Notice of AGM |
| 17:04 | 01-05-2024 | MXCT | Maxcyte | Total Voting Rights |
| 13:05 | 10-04-2024 | MXCT | Maxcyte | Notice of Results |
| 07:00 | 03-04-2024 | MXCT | Maxcyte | Total Voting Rights and Block Listing Return |
| 07:00 | 02-04-2024 | MXCT | Maxcyte | Exercise of options and PDMR dealing |
| 10:05 | 20-03-2024 | MXCT | Maxcyte | Grant of Options, RSUs and PSUs and PDMR Dealing |
| 10:16 | 20-03-2024 | MXCT | Maxcyte | Grant of Options, RSUs and PSUs and PDMR Dealing |
| 07:00 | 13-03-2024 | MXCT | Maxcyte | Reports Q4 & FY 2023 Financial Results |
| 08:58 | 06-03-2024 | MXCT | Maxcyte | TR-1: Notification of major holdings |
| 07:00 | 05-03-2024 | MXCT | Maxcyte | Preliminary FY Results & 2024 Guidance |
| 09:21 | 29-02-2024 | MXCT | Maxcyte | Exercise of options and PDMR dealing |
| 07:00 | 26-02-2024 | MXCT | Maxcyte | TR-1: Notification of major holdings |
| 13:05 | 09-02-2024 | MXCT | Maxcyte | Notice of Results |
| 09:24 | 01-02-2024 | MXCT | Maxcyte | Total Voting Rights |
| 07:00 | 31-01-2024 | MXCT | Maxcyte | Director/PDMR Shareholding |
| 14:29 | 30-01-2024 | MXCT | Maxcyte | Holding(s) in Company |
| 16:52 | 29-01-2024 | MXCT | Maxcyte | TR-1: Notification of major holdings |
| 07:00 | 09-01-2024 | MXCT | Maxcyte | Preliminary Unaudited Q4 and FY 2023 Results |
| 07:00 | 05-01-2024 | MXCT | Maxcyte | Grant of Options and PDMR Dealing |
| 09:23 | 02-01-2024 | MXCT | Maxcyte | Total Voting Rights |
| 07:00 | 02-01-2024 | MXCT | Maxcyte | Confirmation of Board change |
| 07:00 | 29-12-2023 | MXCT | Maxcyte | Exercise of options and PDMR dealing |
| 07:00 | 12-12-2023 | MXCT | Maxcyte | CEO Transition and Revenue Guidance Update |
| 09:50 | 07-12-2023 | MXCT | Maxcyte | Exercise of options and PDMR dealing |
| 07:00 | 04-12-2023 | MXCT | Maxcyte | Exercise of options and PDMR dealing |
| 17:43 | 01-12-2023 | MXCT | Maxcyte | Total Voting Rights |
| 07:00 | 30-11-2023 | MXCT | Maxcyte | Exercise of options and PDMR dealing |
| 07:00 | 17-11-2023 | MXCT | Maxcyte | Exercise of options and PDMR dealing |
| 07:00 | 09-11-2023 | MXCT | Maxcyte | Third Quarter Results |
| 07:00 | 07-11-2023 | MXCT | Maxcyte | Participation in Upcoming Investor Conferences |
| 13:12 | 01-11-2023 | MXCT | Maxcyte | Total Voting Rights |
| 07:00 | 05-10-2023 | MXCT | Maxcyte | Preliminary Q3 Revenue & FY Revenue Guidance |
| 16:03 | 02-10-2023 | MXCT | Maxcyte | Total Voting Rights |
| 14:28 | 13-09-2023 | MXCT | Maxcyte | TR-1: Notification of major holdings |
| 13:21 | 12-09-2023 | MXCT | Maxcyte | TR-1: Notification of major holdings |
| 16:17 | 05-09-2023 | MXCT | Maxcyte | TR-1: Notification of major holdings |
| 13:05 | 05-09-2023 | MXCT | Maxcyte | Baird Global Healthcare Conference Participation |
| 13:32 | 04-09-2023 | MXCT | Maxcyte | TR-1: Notification of major holdings |
| 07:00 | 04-09-2023 | MXCT | Maxcyte | Total Voting Rights |
| 09:01 | 01-09-2023 | MXCT | Maxcyte | Exercise of options and PDMR dealing |
| 17:25 | 18-08-2023 | MXCT | Maxcyte | TR-1 |
| 16:27 | 17-08-2023 | MXCT | Maxcyte | TR-1: Notification of major holdings |
| 07:00 | 17-08-2023 | MXCT | Maxcyte | TR-1: Notification of Major Holdings |
| 07:00 | 10-08-2023 | MXCT | Maxcyte | Second Quarter and Half-Year Results |
| 15:15 | 08-08-2023 | MXCT | Maxcyte | TR-1: Notification of major holdings |
| 17:01 | 07-08-2023 | MXCT | Maxcyte | Total Voting Rights and Block Listing Return |
| 14:31 | 26-07-2023 | MXCT | Maxcyte | TR-1: Notification of major holdings |
| 17:08 | 24-07-2023 | MXCT | Maxcyte | TR-1: Notification of major holdings |
| 17:06 | 24-07-2023 | MXCT | Maxcyte | TR-1: Notification of major holdings |
| 13:05 | 13-07-2023 | MXCT | Maxcyte | Notice of Second Quarter 2023 Financial Results |
| 07:00 | 11-07-2023 | MXCT | Maxcyte | TR-1: Notification of major holdings |
| 07:00 | 10-07-2023 | MXCT | Maxcyte | TR-1: Notification of major holdings |
| 09:23 | 07-07-2023 | MXCT | Maxcyte | Total Voting Rights |
| 15:19 | 29-06-2023 | MXCT | Maxcyte | TR-1: Notification of major holdings |
| 07:00 | 29-06-2023 | MXCT | Maxcyte | TR-1: Notification of major holdings |
| 07:00 | 29-06-2023 | MXCT | Maxcyte | Exercise of options and PDMR dealing |
| 15:46 | 23-06-2023 | MXCT | Maxcyte | Grant of Options |
| 07:17 | 23-06-2023 | MXCT | Maxcyte | Result of AGM |
| 07:00 | 23-06-2023 | MXCT | Maxcyte | Result of AGM |
| 10:10 | 21-06-2023 | MXCT | Maxcyte | Publication of Annual Report |
| 12:32 | 16-06-2023 | MXCT | Maxcyte | Exercise of options and PDMR dealing |
| 07:00 | 02-06-2023 | MXCT | Maxcyte | Upcoming Investor Conferences |
| 07:00 | 01-06-2023 | MXCT | Maxcyte | Total Voting Rights |
| 07:00 | 11-05-2023 | MXCT | Maxcyte | First Quarter Financial Results |
| 07:00 | 09-05-2023 | MXCT | Maxcyte | Exercise of options and PDMR dealing |